after the drugmaker reported positive results from a late-stage trial of a GLP-1 treatment for Type 2 diabetes and obesity in pill form. The last time the stock rose as much was June 29 ...

Type 2 diabetes is increasingly affecting young adults due to poor diets and sedentary lifestyles. Early warning signs like fatigue, excessive thirst, and weight gain are often missed. Simple ...

These benefits could help people with or at risk of diabetes. However, scientific research has not yet confirmed them. Many proponents suggest that apple cider vinegar has many potential health ...

Metformin can reduce knee arthritis pain in people without diabetes, study reveals Researchers from Monash University in Australia showed that metformin can reduce knee arthritis pain in people ...

Citation: Repurposed diabetes drug can reduce pain for those with knee arthritis and overweight or obesity, clinical trial shows (2025, April 25) retrieved 10 May 2025 from https://medicalxpress ...

A new type of diabetes that’s linked not to obesity but to malnutrition has been officially recognised, decades after it was first observed in developing countries. The International Diabetes ...

Vitamin D plays a big role in how our bodies handle blood sugar, and low levels are linked to a higher chance of getting diabetes. While scientists are still figuring out if extra vitamin D can ...

In a major breakthrough for diabetes treatment, scientists have found a new way to regenerate insulin-producing cells. This approach could change how type 1 diabetes is treated, moving beyond just ...

The highs and lows of blood glucose aren't just an energy rollercoaster; they could be a key to detecting diabetes risk early and spare you a needle prick or two. Researchers at the University of ...

A new study links two widely prescribed diabetes drugs to a 33–43% lower risk of Alzheimer’s and related dementias, offering hope for repurposing existing treatments to tackle one of aging’s ...

An estimated 25% of Medicaid enrollees had restricted availability of SGLT2 inhibitors and 40% had restricted availability of GLP-1 agents. Availability of GLP-1 receptor agonists with managed ...